Skinvisible Inc
Skinvisible, Inc. focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women's health, pain management, and other markets. The company's flagship product includes I… Read more
Skinvisible Inc (SKVI) - Total Assets
Latest total assets as of September 2025: $133.62K USD
Based on the latest financial reports, Skinvisible Inc (SKVI) holds total assets worth $133.62K USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Skinvisible Inc - Total Assets Trend (2000–2024)
This chart illustrates how Skinvisible Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Skinvisible Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Skinvisible Inc's total assets of $133.62K consist of 26.6% current assets and 73.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 6.5% |
| Accounts Receivable | $5.00K | 3.2% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $116.19K | 73.4% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2000–2024)
This chart illustrates how Skinvisible Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Skinvisible Inc's current assets represent 26.6% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 6.5% of total assets in 2024, up from 0.5% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 73.0% of total assets, an increase from 11.0% in 2000.
- Asset Diversification: The largest asset category is intangible assets at 73.4% of total assets.
Skinvisible Inc Competitors by Total Assets
Key competitors of Skinvisible Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Lonkey Industrial Co Ltd Guangzhou
SHE:000523
|
China | CN¥3.66 Billion |
|
Taiyen Biotech Co Ltd
TW:1737
|
Taiwan | NT$8.26 Billion |
|
Tianjin Yiyi Hygiene Products Co Ltd
SHE:001206
|
China | CN¥2.20 Billion |
|
Hunan Resun Co Ltd
SHE:001218
|
China | CN¥3.08 Billion |
|
Dencare (Chongqing) Oral Care Co. Ltd. A
SHE:001328
|
China | CN¥1.90 Billion |
|
Qingdao Kingking Applied Chemistry Co Ltd
SHE:002094
|
China | CN¥3.19 Billion |
|
C&S Paper Co Ltd
SHE:002511
|
China | CN¥9.17 Billion |
|
Anhui Deli Household Glass Co Ltd
SHE:002571
|
China | CN¥3.08 Billion |
Skinvisible Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Skinvisible Inc generates 0.13x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Skinvisible Inc is currently not profitable relative to its asset base.
Skinvisible Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.01 | 0.01 | 0.02 |
| Quick Ratio | 0.01 | 0.01 | 0.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-4.74 Million | $ -4.62 Million | $ -2.67 Million |
Skinvisible Inc - Advanced Valuation Insights
This section examines the relationship between Skinvisible Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 8.24 |
| Asset Growth Rate (YoY) | -2.9% |
| Total Assets | $158.22K |
| Market Capitalization | $1.30 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Skinvisible Inc's assets at a significant premium ( 8.24x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: Skinvisible Inc's assets decreased by 2.9% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Skinvisible Inc (2000–2024)
The table below shows the annual total assets of Skinvisible Inc from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $158.22K | -2.86% |
| 2023-12-31 | $162.87K | -34.01% |
| 2022-12-31 | $246.79K | +8.58% |
| 2021-12-31 | $227.30K | +13.51% |
| 2020-12-31 | $200.24K | +10.17% |
| 2019-12-31 | $181.76K | -17.53% |
| 2018-12-31 | $220.39K | -65.14% |
| 2017-12-31 | $632.19K | +86.16% |
| 2016-12-31 | $339.60K | -15.21% |
| 2015-12-31 | $400.53K | -38.00% |
| 2014-12-31 | $646.05K | -26.08% |
| 2013-12-31 | $874.00K | +15.92% |
| 2012-12-31 | $754.00K | +153.87% |
| 2011-12-31 | $297.00K | +8.79% |
| 2010-12-31 | $273.00K | +11.89% |
| 2009-12-31 | $244.00K | -32.97% |
| 2008-12-31 | $364.00K | -48.95% |
| 2007-12-31 | $713.00K | -19.62% |
| 2006-12-31 | $887.00K | -30.21% |
| 2005-12-31 | $1.27 Million | -17.89% |
| 2004-12-31 | $1.55 Million | +5.95% |
| 2003-12-31 | $1.46 Million | -11.35% |
| 2002-12-31 | $1.65 Million | -0.66% |
| 2001-12-31 | $1.66 Million | -5.04% |
| 2000-12-31 | $1.75 Million | -- |